Clinical Trial Update: Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues [EARLY_Phase 1]

View source ↗

Summary

This early-phase trial of liraglutide in high-risk obese participants with cognitive concerns related to Multiple Sclerosis or Long COVID has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Multiple Sclerosis
• Obesity

Drugs mentioned

• SAXENDA (liraglutide)
• liraglutide (liraglutide)

Snippet

Sponsor: University of Chicago | Conditions: Multiple Sclerosis, Long COVID | EARLY_Phase 1 | Status: SUSPENDED